IP Library › Granted Patent US 9,365,580
Granted Patent B2
US 9,365,580 · App. 14/945,607 · Granted Jun 14, 2016

Polymorphic forms of naltrexone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,365,580
App. No.
14/945,607
Granted
Jun 14, 2016
Kind
B2
Abstract

This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.

Claims (10)

1. A polymorphic form of naltrexone methanol solvate which is characterized by at least one of:

(a) the X-ray powder diffraction pattern of FIG. 4A ;

(b) the differential scanning calorimetry thermogram of FIG. 16A ; and

(c) the IR-ATR spectrum of FIG. 28A .

2. A pharmaceutical composition comprising the polymorphic form according to claim 1 and a pharmaceutically acceptable carrier.

3. A polymorphic form of naltrexone methanol solvate which is characterized by at least one of:

(a) the X-ray powder diffraction pattern of FIG. 4B ;

(b) the differential scanning calorimetry thermogram of FIG. 16B ; and

(c) the IR-ATR spectrum of FIG. 28B .

4. A pharmaceutical composition comprising the polymorphic form according to claim 3 and a pharmaceutically acceptable carrier.